| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bea3840c0df613e2728bb667de8097ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b79ea840b038ac1315b2082da00b553b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef54169cba3a2b030867826ccfd7954
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69325ff0298968b12a4f2a9f418373ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ef01d7e053c5d3e5636c5a6e5514863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66d62665ab07838f189464b348fc82d3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G59-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L63-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08L63-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-26 |
| filingDate |
2011-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a121d687787cefdd545df77732f4b6cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04fd3a5e12e7b56387c4b8d6845e664c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f130c390192c898c687e59a9113df99d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7120f3e3a89376249e9cca198e524fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a24b69d2a5d03c26cf48890024291a3 |
| publicationDate |
2012-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012190799-A1 |
| titleOfInvention |
Polyamide Curative Composition |
| abstract |
The present invention relates to a polyamide curative composition comprising a reaction product (P) of (1) at least three compounds of formula H 2 NCH 2 CH 2 (NHCH 2 CH 2 ) x NH 2 with x=1 or higher with (2) a dimer fatty acid and (3) a carboxylic monoacid, with the proviso that the composition is free of tetrahydro-pyrimidine-containing compounds and free of piperazine-containing compounds and the proviso that the dimer fatty acid (2) building block of (P) contains less than 50% of non-cyclic dimer fatty acid isomers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102977339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108602938-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113265218-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017136333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10414855-B2 |
| priorityDate |
2010-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |